[go: up one dir, main page]

WO1999064869A3 - Back pain diagnosis and apparatus for use therein - Google Patents

Back pain diagnosis and apparatus for use therein Download PDF

Info

Publication number
WO1999064869A3
WO1999064869A3 PCT/GB1999/001823 GB9901823W WO9964869A3 WO 1999064869 A3 WO1999064869 A3 WO 1999064869A3 GB 9901823 W GB9901823 W GB 9901823W WO 9964869 A3 WO9964869 A3 WO 9964869A3
Authority
WO
WIPO (PCT)
Prior art keywords
back pain
diagnosis
low back
processes
sciatica
Prior art date
Application number
PCT/GB1999/001823
Other languages
French (fr)
Other versions
WO1999064869A2 (en
Inventor
Thomas John Baldwin
Khai Sing Lam
Original Assignee
Univ Nottingham
Thomas John Baldwin
Khai Sing Lam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nottingham, Thomas John Baldwin, Khai Sing Lam filed Critical Univ Nottingham
Priority to AU42797/99A priority Critical patent/AU4279799A/en
Publication of WO1999064869A2 publication Critical patent/WO1999064869A2/en
Publication of WO1999064869A3 publication Critical patent/WO1999064869A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The intervertebral disc is implicated as a source of symptoms of low back pain and sciatica. Degenerative disc disease and inflammatory processes may result in low back pain. The invention identifies the involvement of lysozyme C and tyrosine phosphorylation in low back pain, sciatica and other joint diseases and provides methods and apparatus for diagnosis and uses of these substances, and processes and substances influencing these processes in the treatment and diagnosis of such diseases and conditions.
PCT/GB1999/001823 1998-06-09 1999-06-09 Back pain diagnosis and apparatus for use therein WO1999064869A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU42797/99A AU4279799A (en) 1998-06-09 1999-06-09 Back pain diagnosis and apparatus for use therein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9812290.6 1998-06-09
GBGB9812290.6A GB9812290D0 (en) 1998-06-09 1998-06-09 Back pain diagnosis

Publications (2)

Publication Number Publication Date
WO1999064869A2 WO1999064869A2 (en) 1999-12-16
WO1999064869A3 true WO1999064869A3 (en) 2000-03-02

Family

ID=10833380

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/001823 WO1999064869A2 (en) 1998-06-09 1999-06-09 Back pain diagnosis and apparatus for use therein

Country Status (3)

Country Link
AU (1) AU4279799A (en)
GB (1) GB9812290D0 (en)
WO (1) WO1999064869A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452351B2 (en) 2004-04-16 2008-11-18 Kyphon Sarl Spinal diagnostic methods and apparatus
US7824390B2 (en) 2004-04-16 2010-11-02 Kyphon SÀRL Spinal diagnostic methods and apparatus

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0132830A2 (en) * 1983-07-25 1985-02-13 EASTMAN KODAK COMPANY (a New Jersey corporation) Dry analytical element for alkaline phosphatase assay
DD226017A1 (en) * 1984-06-27 1985-08-14 Adw Ddr TEST STRIPS FOR DETECTING LYSOCYM (EC 3.2.1.17)
EP0277540A1 (en) * 1987-01-23 1988-08-10 Hoechst Aktiengesellschaft Method for the determination of lysozyme activity
EP0381450A2 (en) * 1989-01-31 1990-08-08 Hybritech Incorporated Assay for bone alkaline phosphatase
WO1992010760A1 (en) * 1990-11-30 1992-06-25 Monoclonetics International, Incorporated Methods for the diagnosis of chronic lower back and cervical pain
WO1993003377A1 (en) * 1991-07-31 1993-02-18 Ziltener Hermann J Method for the detection of phosphotyrosine residues
EP0741144A1 (en) * 1994-11-11 1996-11-06 International Reagents Corporation Antiannexin-v monoclonal antibody, process for producing the same, and use therof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0132830A2 (en) * 1983-07-25 1985-02-13 EASTMAN KODAK COMPANY (a New Jersey corporation) Dry analytical element for alkaline phosphatase assay
DD226017A1 (en) * 1984-06-27 1985-08-14 Adw Ddr TEST STRIPS FOR DETECTING LYSOCYM (EC 3.2.1.17)
EP0277540A1 (en) * 1987-01-23 1988-08-10 Hoechst Aktiengesellschaft Method for the determination of lysozyme activity
EP0381450A2 (en) * 1989-01-31 1990-08-08 Hybritech Incorporated Assay for bone alkaline phosphatase
WO1992010760A1 (en) * 1990-11-30 1992-06-25 Monoclonetics International, Incorporated Methods for the diagnosis of chronic lower back and cervical pain
WO1993003377A1 (en) * 1991-07-31 1993-02-18 Ziltener Hermann J Method for the detection of phosphotyrosine residues
EP0741144A1 (en) * 1994-11-11 1996-11-06 International Reagents Corporation Antiannexin-v monoclonal antibody, process for producing the same, and use therof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Columbus, Ohio, US; XP002900782 *
DATABASE WPI Derwent World Patents Index; XP002900781 *
DATABASE WPI Derwent World Patents Index; XP002900783 *
DATABASE WPI Derwent World Patents Index; XP002900784 *
DATABASE WPI Derwent World Patents Index; XP002900785 *

Also Published As

Publication number Publication date
GB9812290D0 (en) 1998-08-05
AU4279799A (en) 1999-12-30
WO1999064869A2 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
EA199900349A1 (en) CATALYTIC SUB-UNIT OF HUMAN TELOMERASE
BRPI0410296A (en) system and method for determining the efficacy of treatment of neurological disorders using electroencephalogram
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
ATE284959T1 (en) DISRUPTION OF THE BINDING OF THE PROTEINS MDM2 AND P53 AND CORRESPONDING THERAPEUTIC APPLICATION
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
WO2003055443A3 (en) Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
YU18400A (en) Prostaglandin agonists and their use to treat bone disorders
MX9704030A (en) 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
NO307027B1 (en) Use of riluzole in the treatment of neurological lesions related to traumatic injuries
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
PT942740E (en) COMBINATION THERAPY USING A TNF LIGACTION PROTEIN FOR TREATMENT OF TNF-MEDIATED DISEASES
AU6257798A (en) Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
NO965098D0 (en) Perfluoroalkyl ketone inhibitors of elastase and methods for their preparation
GR3001738T3 (en) Pyrrolocarbazole derivatives, processes for their preparation and their use as medicaments
NO972391L (en) 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and their preparations and methods
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
RU95111308A (en) Derivatives of 2-amino-4-phenyl-4-oxobutyric acid, methods of synthesis, pharmaceutical composition
WO2002046384A3 (en) Kinases and phosphatases sequences, and use thereof
IT1290781B1 (en) ACTIVE THERAPEUTIC AGENT FOR THE TREATMENT OF NEURONAL DEGENERATIVE DISEASES.
WO1999064869A3 (en) Back pain diagnosis and apparatus for use therein
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
MY129782A (en) Novel medical use
WO1999009199A3 (en) Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
IL111196A0 (en) Peptides and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase